Medical artificial intelligence needs governance to ensure safety and effectiveness, not just centrally (for example, by the US Food and Drug Administration) but also locally to account for differences in care, patients and system performance. Practical collaborative governance will enable health systems to carry out these challenging governance tasks, supported by central regulators.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Wong, A. et al. JAMA Internal Med. 181, 1065–1070 (2021).
Price II, W. N. SMU Sci. Tech. L. Rev. 25, 3–21 (2022).
Wong, A. et al. JAMA Netw. Open 4, e2135286 (2021).
Obermeyer, Z., Powers, B., Vogeli, C. & Mullainathan, S. Science 366, 447–453 (2019).
Price II, W. N., Gerke, S. & Cohen, I. G. J. Am. Med. Assoc. 322, 1765–1766 (2019).
Sendak, M. P., Gao, M., Brajer, N. & Balu, S. NPJ Digit. Med. 3, 1–4 (2020).
Panch, T. et al. PLoS Digit. Health 1, e0000040 (2022).
Sendak, M. P. et al. Proc. Mach. Learn. Res. 182, 1–19 (2022).
Sendak, M. P., Balu, S. & Schulman, K. A. Appl. Clin. Inform. 8, 826–831 (2017).
Bedoya, A. D. et al. J. Am. Med. Inform. Assoc. 29, 1631–1636 (2022).
Wiens, J. et al. Nat. Med. 25, 1337–1340 (2019).
Sendak, M. P. et al. JMIR Med. Inform. 8, e15182 (2020).
Finlayson, S. G. et al. N. Engl. J. Med. 385, 283–286 (2021).
Kim, J. Y. et al. Proc. 2023 ACM Conference on Fairness, Accountability, and Transparency 1396–1417 (2023).
Sendak, M. P., Price II, W. N. & Balu, S. STAT https://go.nature.com/3pKJNF3 (2022).
US FDA. https://go.nature.com/3negsku (2022).
This research is funded in part by the Gordon and Betty Moore Foundation, through grant GBMF10849 to Duke University to support the work of Health AI Partnership; and in part by the Novo Nordisk Foundation, through grant NNF17SA027784 for a scientifically independent Collaborative Research Programme in Biomedical Innovation Law.
W.N.P. declares no competing interests. M.P.S. is a co-inventor of intellectual property licensed by Duke University to Clinetic, Inc., KelaHealth, Inc. and Cohere-Med, Inc. M.P.S. holds equity in Clinetic, Inc. S.B. is a co-inventor of intellectual property licensed by Duke University to Clinetic, Inc. and Cohere-Med, Inc. K.S.’s institution receives grant funding from the US National Institute of Diabetes and Digestive and Kidney Diseases, Blue Cross Blue Shield of Michigan and Teva Pharmaceuticals for unrelated work. K.S. previously served on a scientific advisory board for Flatiron Health and received consulting fees.
Peer review information
Nature Machine Intelligence thanks Vasiliki Rahimzadeh for their contribution to the peer review of this work.
About this article
Cite this article
Price, W.N., Sendak, M., Balu, S. et al. Enabling collaborative governance of medical AI. Nat Mach Intell 5, 821–823 (2023). https://doi.org/10.1038/s42256-023-00699-1